CACI enters its fiscal first-quarter report with an unusual setup: management has handed Wall Street a full-year outlook that sits above consensus, yet the quarter on deck is expected to show earnings falling year over year. That gap between a bullish annual plan and a soft near-term print is the story. The September quarter will offer the first real evidence of whether the fiscal 2027 targets are credible or simply depend on a heroic second half.
Analysts expect earnings of $6.45 per share on revenue of about $2.50 billion. That works out to sales growth of roughly 9% but a profit decline of nearly 6% from the $6.85 earned a year ago. The Earnings Whisper of $6.74 sits about 4.5% above consensus. That is a meaningful cushion, and it suggests the informal bar is set closer to flat earnings than to a decline. Over the full year, management guided to adjusted earnings of $32.96 to $33.86 per share on revenue of $10.65 billion to $10.85 billion. Consensus of $31.28 and $10.58 billion falls below the bottom of both ranges, so the Street is effectively betting that CACI cannot deliver its own plan. A first quarter that tracks ahead of analyst models would put pressure on those estimates to rise.
Management already warned that organic growth this quarter would run in the low single digits, reflecting how revenue is weighted between the first and second halves. Most of the projected top-line growth should therefore come from ARCA, which contributes roughly $500 million of acquired revenue to the year. Investors should focus on what happens beneath that headline. The guide calls for EBITDA margin in the high-12% range, about 50 basis points above fiscal 2026's 12.3%. Early margin progress, even modest, would support the view that a richer technology mix is lifting profitability rather than just adding volume. Management has also flagged that roughly 35% of the technology business is fixed-price, which makes quarters lumpier. A margin dip could be timing, but it would need a convincing explanation.
The demand indicators matter more than usual because last quarter brought a wave of new catalysts. Funded backlog rose 29%, and bids under evaluation jumped to about $11 billion from roughly $4 billion a quarter earlier. Total backlog grew just 2%, though, and management argued that traditional book-to-bill and duration metrics are becoming less useful as OTA and commercial-style contracts grow. This report will show whether that explanation holds up. Converting the bid pile into awards, along with updates on Spectral's move into low-rate production, the $500 million Domestic Shield counter-drone work, and the combined CACI and ARCA space wins, would validate the story. Another quarter of flat total backlog combined with slow award activity would invite skepticism. Free cash flow toward the target of at least $900 million and continued deleveraging toward the low-3s are secondary but useful checks.
The market has already bought in. Shares have climbed about 11% since the last report against a roughly flat S&P 500, and at $614 the stock trades well above its 200-day average and entirely above the prior quarter's range. It sits about 10% below its post-earnings high of $683, so it has cooled from its peak but has not broken down. Sentiment has also improved, moving from moderately bearish to roughly neutral.
The central question is whether the first quarter looks like the opening leg of a year that beats consensus or a warning that the back half carries too much weight. Steady margins, visible award conversion and a reaffirmed or raised guide would keep the narrative intact. A soft quarter paired with vague timing on new programs would hand the skeptics a better argument.